文献速递血管炎

糖皮质激素剂量与巨细胞动脉炎复发:单中心队列研究

Glucocorticoid dosing and relapses in giant cell arteritis-a single centre cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该单中心回顾性队列纳入54例经活检或影像确诊的新发巨细胞动脉炎(GCA)患者,分析真实世界糖皮质激素(GC)剂量与复发的关系。结果显示44%患者复发,仅5例(21%)复发可能通过遵循推荐GC方案预防;甲氨蝶呤(MTX)治疗与复发减少无显著关联(P=0.178)。

要点

  • 44%的GCA患者复发,即使采用低剂量缓慢减量且累积泼尼松剂量较高的长期GC方案。
  • 仅21%的复发可能通过遵循推荐GC方案预防。
  • MTX治疗与复发减少无显著关联(P=0.178)。

核心结论

  • 尽管采用低剂量范围缓慢减量且累积泼尼松剂量较高的长期GC方案,44%的新发GCA患者仍复发。
  • 仅5例(21%)复发可能通过遵循推荐GC方案预防。
  • MTX治疗与复发减少无显著关联(P=0.178)。

研究设计与样本

  • 单中心回顾性队列研究,连续纳入54例经活检或影像确诊且随访至停用GC的新发GCA患者。
  • 从住院和门诊记录中分析GC剂量、其他免疫调节药物及复发情况。

主要发现

  • 54例患者中24例(44%)复发。
  • 25%剂量百分位患者起始无需冲击治疗者第40天泼尼松剂量≤15 mg,第169天(24周后)≤7.5 mg,第496天(70周)停用泼尼松。
  • 25%剂量百分位累积泼尼松剂量达3.74 g。
  • 24例复发者中仅4例停用GC明显早于25%剂量百分位(17-58周),1例低于25%GC百分位>10%。
  • MTX治疗与复发减少无显著关联(P=0.178)。

关键数值与推荐

  • 25%剂量百分位患者第40天泼尼松剂量≤15 mg,第169天≤7.5 mg,第496天停用泼尼松。
  • 25%剂量百分位累积泼尼松剂量为3.74 g。
  • 25%剂量百分位患者在第4周至第12周低于英国风湿病学会(BSR)推荐剂量,第14周后高于推荐剂量。

临床怎么用

  • 真实世界中GCA患者即使遵循缓慢减量策略,复发率仍较高,需关注GC相关累积剂量。
  • 遵循推荐GC方案可能仅能预防少数复发,提示需探索其他免疫调节策略。
  • MTX治疗在本队列中未显示显著减少复发的作用。

局限性

  • 单中心回顾性研究,样本量较小(54例)。
  • 未报告其他免疫调节药物的具体使用情况。
  • 复发预防的归因分析基于剂量百分位比较,可能存在混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the relationship between real life glucocorticoid (GC) dosing and relapse rates in patients with new onset GCA in a single centre. METHODS: Complete clinical data taken from the inpatient and outpatient records of consecutive GCA patients followed beyond stopping GC were retrospectively analysed for GC doses, other immunomodulatory agents and relapses. RESULTS: We included 54 patients with GCA confirmed by biopsy or imaging and followed over their complete GC course. In the 25% dose percentile, patients who needed no pulse therapy at onset reached a dose of 15 mg prednisolone or lower at day 40, of 7.5 mg prednisolone or lower on day 169 (after 24 weeks), and were off prednisolone on day 496 (70 weeks). They were below British Society for Rheumatology recommended doses between week 4 and week 12 and above these after week 14. The cumulative prednisolone dose reached in this 25% quartile was 3.74 g. Of the 54 patients, 24 (44%) relapsed, only four of whom had stopped GC clearly (17-58 weeks) earlier than the 25% dose quartile and one was distinctly (>10%) below the 25% GC percentile. MTX treatment was not significantly associated with fewer relapses (P = 0.178). CONCLUSION: Despite a long-term GC regimen with slow rates of reduction in the low dose range and high cumulative prednisolone doses, 44% of the patients relapsed. Only five (21%) of these relapses may have been prevented by adhering to the recommended GC regimen.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Felten L, Leuchten N, Aringer M, et al. Glucocorticoid dosing and relapses in giant cell arteritis-a single centre cohort study. Rheumatology (Oxford). 2022. PMID: 34487149. doi:10.1093/rheumatology/keab677

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。